August 18, 2021 2:00 pm – 5:00 pm
Annual Sickle Cell Adult Provider Symposium, Bethesda, MD,
Chairs: Dr. Susanna Curtis, MD PhD and Dr. John Strouse MD PhD
Disease Modifying Therapy for Adults with Sickle Cell Disease: What and When to Choose?
0200-205: Welcome and Introduction - Susanna Curtis MD PhD
An Era of Multiple Therapuetics Montefiore Medical Center
Bronx NY
Best Practices in Current Therapeutic and Curative Options
0205-0225: Hydroxyurea as the Cornerstone of Therapy Sophie Lanzkron, MD
Johns Hopkins University,
Baltimore, MD
0230-0250: When to use Red Blood Cell Transfusions Ross Fasano, MD
Emory University
Atlanta, GA
255-0315: Who Should be Referred for Curative Therapy Emily Limerick, MD
National Institutes of Health
Baltimore, MD
Debates on New Therapeutic Agents: Which to use and When?
L-Glutamine
0320-0330: Pro L-Glutamine Claudia Morris, MD
Emory University
Atlanta, GA
0330-0340: Anti L-Glutamine Dr. Marquita Nelson, MD
University of Tennessee Health Science Center
Memphis, TN
Voxelotor
0345-0355: Pro Voxelotor Modupe Idowu, MD
University of Texas Health Science Center at Houston,
Houston, TX
0355-0405: Anti Voxelotor Dr. Payal Desai, MD
Ohio State University,
Columbus, OH
Crizanlizumab
0405-4:15: Pro Crizanlizumab Foluso Ogunsile, MD
University of Alabama at Birmingham,
Birmingham, AL
0415-0425: Anti Crizamlizumab Dr. John Strouse MD PhD
Duke University
Durham, NC
0430- 0500: Panel Discussion: All speakers Drs. Curtis, Lanzkron, Fasano, Limerick, Morris, Nelson, Idowu, Desai, Ogunsile, Strouse
Panel moderators Drs. Curtis and Strouse
Closing remarks / Evaluations